Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Operating Income: 2013-2024

Historic Operating Income for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to -$187.7 million.

  • Soleno Therapeutics' Operating Income fell 183.62% to -$5.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$12.2 million, marking a year-over-year decrease of 17.49%. This contributed to the annual value of -$187.7 million for FY2024, which is 353.49% down from last year.
  • Soleno Therapeutics' Operating Income amounted to -$187.7 million in FY2024, which was down 353.49% from -$41.4 million recorded in FY2023.
  • Over the past 5 years, Soleno Therapeutics' Operating Income peaked at -$24.4 million during FY2022, and registered a low of -$187.7 million during FY2024.
  • For the 3-year period, Soleno Therapeutics' Operating Income averaged around -$84.5 million, with its median value being -$41.4 million (2023).
  • Data for Soleno Therapeutics' Operating Income shows a maximum YoY crashed of 353.49% (in 2024) over the last 5 years.
  • Soleno Therapeutics' Operating Income (Yearly) stood at -$24.4 million in 2022, then plummeted by 69.63% to -$41.4 million in 2023, then plummeted by 353.49% to -$187.7 million in 2024.